Sedia Biosciences Corporation
Beaverton, OR Doing business as Sedia Biosciences Corp
- UEI
- LB3AM53JKK33
- CAGE
- 5UEH4
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Sedia Biosciences Corporation
LB3AM53JKK33
- Floragenex, Inc. Y32FU3MMP6C5
-
Sedia Biosciences Corporation
LB3AM53JKK33
- SAM.gov registration date
- Physical address
- 9590 SW Gemini Dr #120, Beaverton, OR 97008, USA
- Website
- sediabio.com
- Founded
- 2009
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Lab supplies and equipment - sedia rapid recency kits | CDC Pittsburgh | $82,263 | |
| Lab supplies - sedia asante rapid recency assay kits | CDC Pittsburgh | $119,155 | |
| Sedia biosciences lab supplies | CDC Pittsburgh | $149,825 | |
| Sedia lab supply | CDC Pittsburgh | $0 | |
| Asante rapid recency kits and reader | CDC Pittsburgh | $112,060 |
About Sedia Biosciences Corporation
Sedia Biosciences Corporation, doing business as Sedia Biosciences Corp, is a privately held medical device and diagnostics company that provides laboratory supplies and equipment to support disease monitoring and prevention programs. Through federal contract awards, the company has provided rapid HIV recency assay kits, laboratory reagents, and related equipment to the Centers for Disease Control and Prevention (CDC) and prime contractors supporting CDC programs.
Specifically, Sedia Biosciences Corp has been awarded CDC purchase orders totaling over $350,000 to provide rapid recency kits, assay kits, and other laboratory supplies delivered to CDC facilities in Pittsburgh, Pennsylvania. These firm fixed price awards, made between 2019-2023, support CDC disease surveillance and prevention initiatives domestically. Additionally, in 2020 Sedia was a subcontractor to Chemonics International Inc. under a CDC task order to supply HIV-1 rapid recency assays for CDC programs in Rwanda. No set aside designations were associated with these awards to Sedia Biosciences Corp.
SBA capabilities narrative
Sedia is a leader in the development of novel in-vitro diagnostic assays using alternative fluid specimens (e.g. oral fluid, urine) for disease detection. Sedia is also the leading manufacturer of HIV incidence type assays.
Quick answers
What is Sedia Biosciences Corporation's UEI?
Sedia Biosciences Corporation's Unique Entity ID (UEI) in SAM.gov is LB3AM53JKK33.
What is Sedia Biosciences Corporation's CAGE code?
Sedia Biosciences Corporation's CAGE code is 5UEH4.
What is Sedia Biosciences Corporation's primary NAICS code?
Sedia Biosciences Corporation's primary NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing).
Where is Sedia Biosciences Corporation located?
Sedia Biosciences Corporation's physical address in SAM.gov is 9590 SW Gemini Dr #120, Beaverton, OR 97008, USA.
Is Sedia Biosciences Corporation registered in SAM.gov?
Sedia Biosciences Corporation's SAM.gov registration expired on August 27, 2026.
What is Sedia Biosciences Corporation's most recent federal award?
Sedia Biosciences Corporation's most recent federal contract award is Lab supplies and equipment - sedia rapid recency kits (75D30123P17526), from CDC Pittsburgh, on September 15, 2023.
On GovTribe
See Sedia Biosciences Corporation's full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors